pharmaceuticals

Finance

16 September, 2022

Mankind files for IPO; promoters, early investors to participate

ChrysCapital-backed healthcare player Mankind Pharma has filed draft papers for its initial public offering with markets regulator Securities and Exchanges ......

Premium

Healthcare

11 July, 2022

Analysis: M&A deal value in healthcare and pharma hits record high in Jan-June

Merger and acquisitions (M&As) deal value in the healthcare and pharmaceutical space hit a record high in Jan-June, crossing the ......

Healthcare

11 May, 2022

PAG consortium to acquire controlling stake in Optimus group firms

Asian alternative investment firm PAG has agreed to buy a controlling stake in three group entities of Hyderabad-based drugmaker Optimus ......

Healthcare

25 April, 2022

InvAscent invests Rs 250 cr in bulk drugs firm Malladi

Healthcare focused private equity firm InvAscent has invested Rs 250 crore in bulk drugs maker Malladi Drugs and Pharmaceuticals Ltd ......

Premium

Healthcare

24 December, 2021

Healthcare 2021: Healthtech shines; diagnostics, hospitals keep up with IPOs, M&As

India’s healthtech segment made great strides in 2021, with the landmark acquisition of a listed company - Thyrocare Technologies, by ......

General

28 January, 2021

Grapevine: Five bidders vie for Reliance Home Finance; Carlyle eyes pharma assets

Five bidders — Kotak Special Situations Fund, Capri Global, Asset Reconstruction Company (India) Ltd (Arcil), Acre ARC and Authum Investment ......

Premium

Healthcare

22 December, 2020

Flashback 2020: Vaccine makers, healthtech in spotlight as Covid-19 rages

Indian vaccine makers took centre stage in 2020 as the country and emerging markets pinned their hopes on them to ......

Healthcare

27 July, 2020

Govt to boost drug and medical device production to cut imports

India’s chemicals minister on Monday outlined plans to boost local manufacturing in the bulk drugs and medical device industries to ......

Premium

Healthcare

03 February, 2020

ChrysCapital returns as investor in another pharma firm after taking it public

Homegrown private equity firm ChrysCapital has returned to invest in a pharmaceutical company that it had helped launch on the ......

Premium

Healthcare

24 December, 2019

Flashback 2019: Single-specialty, regional hospitals steal the thunder in healthcare

A strong revival of investor interest in eye-care clinics, big-ticket deals in the dialysis, fertility and oncology segments and a ......